Join Us at ProcureCon PHARMA in Frankfurt, Germany March 19-20, 2019

Posted by Sandra Hageman on Mar 11, 2019 11:14:46 AM

 

Transforming Pharma Procurement. Together.

Eurofins BioPharma Services looks forward to meeting you at the ProcureCon PHARMA meeting in Frankfurt, Germany from March 19-20, 2019.

Read More

Tags: Central Laboratory, Clinical Trial, BioPharma, Leadership, Pharma Procurement

Eurofins Celebrates International Women's Day

Posted by Jesse Gehris on Mar 8, 2019 10:30:11 AM

Today, on March 8th, 2019, Eurofins Central Laboratory, a member of Eurofins BioPharma Services, celebrates International Women's Day (IWD).

Read More

Tags: Central Laboratory, Quality, Results, Peace, Development, BioPharma, Leadership, International Women's Day

Happy Chinese New Year 2019!

Posted by Sandra Hageman on Feb 5, 2019 11:09:26 AM

新年快乐

Read More

Tags: Quality, Peace, Development, BioPharma, Chinese New Year, Year of the Pig

World Leprosy Day

Posted by Jesse Gehris on Jan 27, 2019 9:00:00 AM

On January 27th,  Eurofins Central Laboratory recognizes World Leprosy Day with the World Health Organization (WHO). Also known as Hansen’s disease, Leprosy is a chronic infectious disease caused by Mycobacterium Leprae. This disease affects the skin, peripheral nerves, mucus membranes of the upper respiratory tract, and eyes. Individuals affected will experience sensory loss in these affected areas as well as damaged thickened nerves.

Read More

Tags: Central Laboratory, Drug Development, Bioanalytical Testing, BioPharma, Leprosy

Moebius Syndrome Awareness Day

Posted by Jesse Gehris on Jan 24, 2019 9:00:00 AM

Today we at Eurofins Central Laboratory recognize a rare neurological disorder known as Moebius Syndrome.

Read More

Tags: Central Laboratory, Clinical Trial, Bioanalytical Testing, Development, Science Education, BioPharma, Moebius Syndrome

Neurodegenerative Disease Treatments

Posted by Tracy Hendershott on Jan 14, 2019 9:00:00 AM

While we have numerous symptomatic treatments today, there is still no cure for neurodegenerative diseases such as Parkinson’s and Alzheimer’s. There are more than 600 neurodegenerative diseases alone that affect the brain, spine, and peripheral nervous system. While diseases like Parkinson’s affect motor functions, Alzheimer’s is a progressive disease that destroys memory and other mental functions.

Read More

Tags: Central Laboratory, BioPharma, Alzheimer's Disease, Neurodegenerative, Parkinson's Disease

Eurofins Central Laboratory Celebrates 30 Years of GLP

Posted by Sandra Hageman on Jan 7, 2019 9:00:00 AM

 

Celebrating Thirty Years of Good Laboratory Practice

The GLP (Good Laboratory Practice) Testing Facility of Eurofins Central Laboratory in Breda, The Netherlands has been accredited for OECD GLP for over 30 years. It all started at the BCO Centre for Research (B for Bergschot 71, the street address ever since) with the first inspection by the Dutch Health Care Inspectorate in June 1988. Over the years, BCO underwent several transformations and evolved into becoming one of the Eurofins Central Laboratory facilities, keeping the GLP Test Facility embedded in the Breda Clinical Laboratory.

Read More

Tags: Central Laboratory, Quality, Results, Bioanalytical Testing, BioPharma

Stress Urinary Incontinence

Posted by Tracy Hendershott on Nov 27, 2018 9:00:00 AM

Currently, there aren't any globally-approved pharmaceutical treatments for Stress Urinary Incontinence (SUI). With a predominately female patient population ranging in the hundreds of millions of people worldwide, this provides them with only surgical and physical therapy-based options, limiting their choice of solutions. While effective for some, there can be challenges that come with the invasive nature of surgical procedures, as well as non-compliance with the length of time required for successful physical therapy outcomes. 

Read More

Tags: Pharmaceutical, BioPharma, Stress Urinary Incontinence

World Prematurity Day

Posted by Tracy Hendershott on Nov 16, 2018 9:00:00 AM

On November 17th, 2018, we celebrate World Prematurity Day with March of Dimes. According to March of Dimes, "Premature birth is the leading cause of death in children under the age of five worldwide. Babies born too early may have more health issues than babies born on time, and may face long-term health problems that affect the brain, the lungs, hearing or vision."

Read More

Tags: Central Laboratory, Prematurity, BioPharma